MAM
CVS icon

Martingale Asset Management’s CVS Health CVS Stock Holding History

Martingale Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
11,692
+4,780
+69% +$427K 0.03% 496
2026
Q1 		$496K Buy
+6,912
New +$532K 0.01% 638
2024
Q4 		– Sell
-4,712
Closed -$296K – 779
2024
Q3 		$296K Sell
4,712
-1,877
-28% -$110K 0.01% 710
2024
Q2 		$389K Buy
6,589
+1,817
+38% +$114K 0.01% 655
2024
Q1 		$381K Sell
4,772
-378
-7% -$28.9K 0.01% 666
2023
Q4 		$407K Sell
5,150
-63
-1% -$4.48K 0.01% 645
2023
Q3 		$364K Sell
5,213
-303,674
-98% -$21.5M 0.01% 658
2023
Q2 		$21.4M Sell
308,887
-82,365
-21% -$5.86M 0.42% 91
2023
Q1 		$29.1M Buy
391,252
+9,812
+3% +$823K 0.56% 67
2022
Q4 		$35.5M Buy
381,440
+38,374
+11% +$3.7M 0.69% 42
2022
Q3 		$32.7M Buy
343,066
+272,866
+389% +$27M 0.65% 51
2022
Q2 		$6.5M Buy
70,200
+67,290
+2,312% +$6.57M 0.12% 165
2022
Q1 		$295K Buy
2,910
+205
+8% +$21.5K ﹤0.01% 726
2021
Q4 		$280K Buy
2,705
+71
+3% +$6.56K ﹤0.01% 751
2021
Q3 		$224K Buy
+2,634
New +$221K ﹤0.01% 801
2020
Q3 		– Sell
-7,612
Closed -$495K – 1037
2020
Q2 		$495K Buy
7,612
+3,069
+68% +$193K 0.01% 878
2020
Q1 		$270K Buy
+4,543
New +$303K ﹤0.01% 893
2019
Q2 		– Sell
-5,081
Closed -$275K – 1019
2019
Q1 		$275K Buy
5,081
+4
+0.1% +$247 ﹤0.01% 962
2018
Q4 		$333K Sell
5,077
-3,245
-39% -$242K ﹤0.01% 909
2018
Q3 		$656K Sell
8,322
-773
-8% -$55.3K 0.01% 802
2018
Q2 		$586K Sell
9,095
-22,570
-71% -$1.49M 0.01% 837
2018
Q1 		$1.97M Sell
31,665
-57,631
-65% -$4.13M 0.03% 536
2017
Q4 		$6.47M Sell
89,296
-13,847
-13% -$1.01M 0.09% 224
2017
Q3 		$8.39M Buy
103,143
+525
+0.5% +$41.5K 0.11% 191
2017
Q2 		$8.26M Buy
102,618
+59,879
+140% +$4.73M 0.12% 187
2017
Q1 		$3.36M Sell
42,739
-542,995
-93% -$43.3M 0.05% 403
2016
Q4 		$46.2M Buy
585,734
+93,984
+19% +$7.6M 0.65% 21
2016
Q3 		$43.8M Buy
491,750
+111,474
+29% +$10.5M 0.65% 22
2016
Q2 		$36.4M Buy
380,276
+79,097
+26% +$7.88M 0.6% 36
2016
Q1 		$31.2M Buy
301,179
+29,296
+11% +$2.85M 0.62% 25
2015
Q4 		$26.6M Sell
271,883
-25,406
-9% -$2.49M 0.59% 31
2015
Q3 		$28.7M Sell
297,289
-19,900
-6% -$2.09M 0.7% 24
2015
Q2 		$33.3M Buy
317,189
+89,601
+39% +$9.15M 0.78% 16
2015
Q1 		$23.5M Buy
227,588
+67,647
+42% +$6.84M 0.56% 32
2014
Q4 		$15.4M Buy
159,941
+27,197
+20% +$2.4M 0.43% 54
2014
Q3 		$10.6M Buy
132,744
+3,351
+3% +$264K 0.33% 77
2014
Q2 		$9.75M Buy
129,393
+4,168
+3% +$315K 0.31% 95
2014
Q1 		$9.38M Buy
125,225
+18,777
+18% +$1.33M 0.32% 85
2013
Q4 		$7.62M Sell
106,448
-237,576
-69% -$15.3M 0.26% 103
2013
Q3 		$19.5M Sell
344,024
-45,206
-12% -$2.69M 0.7% 20
2013
Q2 		$22.3M Buy
+389,230
New +$22.6M 0.82% 14

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Martingale Asset Management's CVS Position: Q2 2026 in Review

Martingale Asset Management increased its CVS Health (CVS) stake by 69% in Q2 2026, buying an estimated $427K and bringing the position to 11,692 shares worth $1.21M. The position accounts for 0.03% of the portfolio, ranked #496.

Martingale Asset Management first reported a position in CVS in Q2 2013 and has held it in 41 quarters since. The position peaked at $46.2M in Q4 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Martingale Asset Management held 11,692 shares of CVS Health worth $1.21M as of Q2 2026.
  • Martingale Asset Management bought 4,780 CVS Health shares in Q2 2026, an estimated $427K.
  • CVS Health made up 0.03% of Martingale Asset Management's portfolio in Q2 2026, its #496 holding.
  • Martingale Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 41 quarters since.
  • Martingale Asset Management's CVS Health position peaked at $46.2M in Q4 2016.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.